首页> 外文期刊>The National medical journal of India >D-dimer levels in patients with thromboangiitis obliterans
【24h】

D-dimer levels in patients with thromboangiitis obliterans

机译:血栓栓塞患者的D-二聚体水平

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Thromboangiitis obliterans (TAO) or Buerger disease is a recurring progressive segmental vasculopathy that presents with inflammation and thrombosis of small and medium arteries and veins of the hands and feet. The exact cause remains unknown, with tobacco use (primarily smoking but also smokeless tobacco) being highly associated with the disease. The diagnosis is clinical and the lack of a diagnostic gold standard is a deterrent to diagnosing it in patients with atypical presentations. Obliterative endarteritis occurs perhaps due to a mixture of thrombosis and inflammation. The diagnostic sensitivity and specificity of D-dimer as a biomarker for thrombosis is well reported from its use in other areas such as deep vein thrombosis. Identification of a biomarker linked to the causation yields a diagnostic adjunct with a role in therapeutic decision-making, aiding diagnosis in atypical presentation, monitoring disease activity and gauging response to therapy. Methods. Between April 2014 and May 2015, we studied serum D-dimer (a marker of thrombosis) in 62 patients with TAO and compared this to 330 normal age- and sex-matched controls. We included all patients with peripheral arterial disease clinically diagnosed to have TAO according to the Shionoya criteria. There was no history of thrombosis or arterial disease in the control group. The control group was matched for baseline characteristics such as age and sex. All patients underwent a standard diagnostic protocol including blood tests (haemoglobin and creatinine), electrocardiogram, chest X-ray and ankle brachial pressure index. Blood was collected using an evacuated tube system into a citrate anticoagulant tube for testing D-dimer. Results. All the 62 patients diagnosed to have TAO were men with an average age of 40 years (range 18-65 years). They all had a history of tobacco use and did not have other atherogenic risk factors (part of the diagnostic criteria). Medium-vessel involvement was present in 53 patients (85%) and the rest presented with additional involvement of the popliteal and femoral vessels. Upper limb involvement or superficial thrombophlebitis was present in 95% of patients. Laboratory and imaging studies were consistent with TAO. The groups were well matched for age (p = 0.3). The median and interquartile range for D-dimer values were 61 ng/ml and 41-88 ng/ml in controls (n = 330) and 247 ng/ml and 126-478 ng/ml in patients (n=62), respectively (p<0.001). Conclusions. D-dimer levels are considerably elevated in patients with TAO. This indicates an underlying thrombotic process and suggests its potential role as a diagnostic adjunct. It also leads us to hypothesize a potential therapeutic benefit of anticoagulants in this disease.
机译:出身背景血栓闭塞性脉管炎(TAO)或Buerger病是一种复发性进行性节段性血管病,表现为手和脚的中小动脉和静脉的炎症和血栓形成。确切原因尚不清楚,烟草使用(主要是吸烟,但也包括无烟烟草)与该疾病高度相关。诊断是临床的,缺乏诊断金标准对诊断不典型表现的患者是一种威慑。闭塞性动脉内膜炎的发生可能是由于血栓形成和炎症的混合。D-二聚体作为血栓生物标志物的诊断敏感性和特异性在深静脉血栓形成等其他领域的应用已得到充分报道。识别与病因相关的生物标志物可产生一种诊断辅助物,在治疗决策中发挥作用,在非典型表现中帮助诊断,监测疾病活动和评估治疗反应。方法。2014年4月至2015年5月,我们研究了62例TAO患者的血清D-二聚体(血栓标记物),并将其与330例正常年龄和性别匹配的对照组进行了比较。我们纳入了根据Shionoya标准临床诊断为TAO的所有外周动脉疾病患者。对照组没有血栓形成或动脉疾病史。对照组的年龄和性别等基线特征相匹配。所有患者都接受了标准的诊断方案,包括血液检测(血红蛋白和肌酐)、心电图、胸部X光和踝肱压指数。使用真空管系统将血液收集到枸橼酸盐抗凝管中,以检测D-二聚体。后果62名确诊为TAO的患者均为男性,平均年龄为40岁(18-65岁)。他们都有吸烟史,没有其他致动脉粥样硬化风险因素(诊断标准的一部分)。53例(85%)患者出现中度血管受累,其余患者出现额外的腘血管和股血管受累。95%的患者出现上肢受累或浅表血栓性静脉炎。实验室和影像学研究与TAO一致。两组的年龄非常匹配(p=0.3)。对照组(n=330)的D-二聚体值的中位数和四分位范围分别为61纳克/毫升和41-88纳克/毫升,患者(n=62)的中位数和四分位范围分别为247纳克/毫升和126-478纳克/毫升(p<0.001)。结论。TAO患者的D-二聚体水平显著升高。这表明潜在的血栓形成过程,并表明其作为诊断辅助手段的潜在作用。这也导致我们假设抗凝剂对这种疾病有潜在的治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号